dutogliptin: Clinical Trials

9 trials of dutogliptin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 terminated, 1 completed, 1 unknown. 9 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 39Terminated 7, Completed 1, Unknown 1

Follow dutogliptin: new trials by email Literature Review of dutogliptin trials Research Report on dutogliptin

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dutogliptin in Co-administration With Filgrastim in Early Recovery Post-myocardial Infarction
Dutogliptin + Filgrastim, Placebo - ST Elevation Myocardial Infarction
Phase 3UnknownRecardio, Inc.41002023-09-012023-06-05
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone
Dutogliptin, Sitagliptin - Diabetes Mellitus, Type 2
Phase 3TerminatedForest Laboratories1412010-03-012011-09-21
Safety and Efficacy Study of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin
dutogliptin, sitagliptin - Type 2 Diabetes Mellitus
Phase 3TerminatedPhenomix6502009-11-012010-08-11
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone
Placebo, Dutogliptin - Diabetes Mellitus, Type II
Phase 3TerminatedForest Laboratories2522009-08-012011-09-21
Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal Impairment
dutogliptin, placebo, sitagliptin - Type 2 Diabetes Mellitus, Renal Impairment
Phase 3TerminatedPhenomix3602009-08-012010-02-03
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin
Dutogliptin, Placebo - Diabetes Mellitus, Type II
Phase 3TerminatedForest Laboratories6772009-07-012011-09-21
Safety and Efficacy Study of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin
dutogliptin, placebo - Type 2 Diabetes Mellitus
Phase 3TerminatedPhenomix7002009-05-012010-08-11
Long-term Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus
dutogliptin - Type 2 Diabetes Mellitus, Type 2 Diabetes
Phase 3TerminatedPhenomix4502009-03-012010-08-11
Safety and Efficacy Study of Dutogliptin/PHX1149T to Treat Type 2 Diabetes Mellitus
PHX1149T, Placebo - Type 2 Diabetes Mellitus
Phase 3CompletedPhenomix4802008-07-012010-04-13

Conditions studied

Diabetes Mellitus, Type 2 (8)  ·  Diabetes Mellitus (4)  ·  Renal Insufficiency (1)  ·  ST Elevation Myocardial Infarction (1)

Sponsors

Phenomix (5)  ·  Forest Laboratories (3)  ·  Recardio, Inc. (1)

Countries

United States (8)  ·  India (6)  ·  Peru (5)  ·  Argentina (4)  ·  Romania (4)  ·  Ukraine (3)  ·  Belarus (2)  ·  Czechia (2)  ·  Lithuania (2)  ·  Malaysia (2)  ·  Philippines (2)  ·  Poland (2)  ·  Chile (1)  ·  Colombia (1)  ·  Germany (1)

Top investigators

Kaity Posada, PharmD (3)